Moderna Therapeutics

Foundational mRNA patents are subject to the Bayh-Dole Act provisions

Posted on by Luis Gil Abinader

Katalin Karikó and Drew Weissman are often described as the pioneers of the mRNA discoveries that underpin the first COVID-19 vaccines. In 2005 both scientists published a paper reporting that a slightly tweaked version of mRNA that can be administered… Continue Reading →

KEI request to BARDA concerning Moderna obligations to disclose federal funding in patent applications

Posted on by Claire Cassedy

On September 2, 2020, Knowledge Ecology International (KEI) sent a letter to the Biomedical Advanced Research and Development Authority (BARDA) regarding a potential failure by Moderna, Inc. to disclose federal funding in patents supported by BARDA. KEI requested information concerning… Continue Reading →